Exephin 500 mg/vial is a third-generation cephalosporin antibiotic designed for the treatment and prevention of a wide range of bacterial infections. With potent bactericidal activity, Exephin disrupts the synthesis of bacterial cell walls, effectively combating both Gram-positive and Gram-negative organisms. It is particularly valued for its broad-spectrum coverage, stability against beta-lactamases, and long plasma half-life, which allows for convenient once- or twice-daily dosing in most patients.
Exephin 500 mg/vial is suitable for treating serious infections in adults and children, including respiratory, urinary, skin, bone, and systemic infections, as well as for perioperative prophylaxis to prevent postoperative infections.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Exephin 500 mg/vial is indicated for the treatment of:
Lower respiratory tract infections (e.g., pneumonia, bronchitis)
Acute bacterial otitis media
Skin and soft tissue infections
Urinary tract infections
Gonorrhea
Bacterial septicemia
Bone and joint infections
Meningitis
Prevention of postoperative infections
Perioperative prophylaxis for surgery-associated infections
Third-generation Cephalosporin
Exephin 500 mg/vial is a parenteral cephalosporin with broad-spectrum bactericidal activity. Its mechanism involves inhibiting bacterial cell wall synthesis, which leads to bacterial cell death. Key pharmacological features include:
High stability against beta-lactamases
Long plasma half-life (6–9 hours), allowing convenient dosing
Protein binding: ~95%
Excretion: 40–65% unchanged in urine; remainder in bile and feces
Exephin is not metabolized in the body and achieves high concentrations in blood, urine, and tissues, making it highly effective against systemic and localized infections.
Adults:
General infections: 1–2 g IV or IM once daily (or divided into two doses); max 4 g/day
Uncomplicated gonococcal infections: 250 mg IM single dose
Surgical prophylaxis: 1 g IV 30–120 minutes before surgery
Infants and Children (≥1 month):
General infections: 50–75 mg/kg IV or IM once daily (divided doses possible); max 2 g/day
Acute otitis media: 50 mg/kg IM single dose; max 1 g/day
Meningitis: 100 mg/kg IV or IM daily or divided doses; max 4 g/day
Administration:
IM injections should be reconstituted with Lidocaine HCl 1%
IV injections should be reconstituted with water for injection, administered over 2–4 minutes or infused over 30 minutes
Patient tolerance should be checked with a test dose before full administration
Duration: Therapy should continue ≥2 days after symptom resolution, typically 4–14 days; prolonged treatment may be needed for complicated infections.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Hypersensitivity to cephalosporins or other beta-lactam antibiotics
Common and less common side effects include:
Gastrointestinal: diarrhea, nausea, vomiting, stomatitis
Cutaneous: rash, pruritus, urticaria, edema, erythema multiforme
Hematologic: eosinophilia, thrombocytopenia, leukopenia, anemia, neutropenia
Hepatic: elevated SGOT, SGPT, bilirubin
CNS: headache, dizziness, confusion, hyperactivity, convulsions
Local: rare phlebitis with IV administration (minimized by slow injection)
Risk of anaphylactic reactions; immediate treatment with epinephrine and corticosteroids may be needed
Monitor blood counts during prolonged therapy
Gallbladder sludge may occur rarely but is usually reversible
Use cautiously in pregnancy and lactation
Safety in human pregnancy not established; use only if essential
Excreted in low concentrations in breast milk; caution advised
No specific antidote; treatment should be symptomatic and supportive
Store in a cool, dry place below 30°C, protected from light and moisture
Keep out of reach of children
Neonates (<28 days) and premature infants: Not recommended
Elderly: Use caution due to possible reduced organ function
Login Or Registerto submit your questions to seller
No none asked to seller yet